ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1391	National Cancer Institute	Html	en	Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of Wilms tumor.	wilms tumors 0.503727 wilms tumor 0.905843 Wilms tumor development 0.5254 Wilms tumor genetics 0.517912 Wilms Tumor Study-5 0.477443 familial Wilms tumour 0.446601 favorable-histology wilms tumor 0.511105 stage II Wilms 0.439212 unilateral Wilms tumor 0.553115 Wilms tumor patients 0.529584 favorable histology Wilms 0.460427 bilateral Wilms patients 0.460054 Tumor Study Group 0.595101 contralateral Wilms tumor 0.495745 Wilms tumor-Aniridia syndrome 0.439108 preoperative wilms tumor 0.505524 bilateral wilms tumor 0.635902 stromal-type Wilms tumor 0.516983 Wilms tumor surveillance 0.49553 beckwith-wiedemann syndrome 0.43423 inoperable Wilms tumor 0.526248 Group/National Wilms Tumor 0.47873 Low-risk Wilms Tumor 0.474612 histology Wilms tumors 0.433526 Wilms Tumor Study 0.723902	Wilms tumor screening 0.479856 wilms tumor rupture 0.501052 et al. 0.499553 wilms tumor predisposition 0.521351 histology Wilms tumor 0.504567 Wilms tumours 0.453209 COG Wilms tumor 0.518219 SIOP Wilms Tumor 0.504401 Wilms tumour 0.50015 bilateral Wilms tumor. 0.45063 Pediatr Blood Cancer 0.440629 wilms tumor suppressor 0.492641 nonsyndromic Wilms tumor 0.493832 Metachronous bilateral Wilms 0.434751 National Wilms Tumor 0.736085 Med Genet 0.447601 Abstract 0.531043 Clin Oncol 0.453706 familial Wilms tumor. 0.444435 Wilms tumor locus 0.521817 Familial Wilms tumor 0.495658 non-WT1-syndromic Wilms tumor 0.488494 Wilms Tumor Study-3 0.478135 Wilms tumor susceptibility 0.497583	CLICK HERE
1392	National Cancer Institute	Html	en	Childhood Rhabdomyosarcoma Treatment (PDQ®)–Health Professional Version	Treatment of children with rhabdomyosarcoma often includes chemotherapy, radiation therapy, and surgery. For pediatric embryonal, alveolar, and anaplastic rhabdomyosarcoma, learn about the signs, diagnosis, prognosis, treatment regimens, and clinical trials in this expert-reviewed summary.	soft tissue 0.790585 intermediate risk rhabdomyosarcoma 0.445041 rhabdomyosarcoma cases 0.455822 childhood rhabdomyosarcoma 0.593521 rhabdomyosarcoma patients 0.545472 children 0.493211 intergroup rhabdomyosarcoma studies 0.517745 alveolar rhabdomyosarcoma patients 0.515716 rhabdomyosarcoma 0.96522 Int J Radiat 0.504093 advanced extremity rhabdomyosarcoma 0.456564 Radiat Oncol Biol 0.739922 childhood rhabdomyosarcoma incidence 0.473829 pediatric rhabdomyosarcoma patients 0.456936 patients 0.603999 spindle cell rhabdomyosarcoma 0.473635 intermediate-risk rhabdomyosarcoma 0.519136 Rhabdomyosarcoma Study-IV experience 0.444462 biliary tract rhabdomyosarcoma 0.443533 Rhabdomyosarcoma Study Group 0.470276 extremity rhabdomyosarcoma 0.461496 adult rhabdomyosarcoma patients 0.499141 soft tissue sarcoma 0.736147 et al. 0.806046 Intergroup Rhabdomyosarcoma Study 0.799018	intergroup rhabdomyosarcoma study-iv 0.552013 differentiated embryonal rhabdomyosarcoma 0.474756 PUBMED Abstract 0.447631 Pediatr Blood Cancer 0.665669 intermediate-risk rhabdomyosarcoma patients 0.477987 nonmetastatic rhabdomyosarcoma 0.468047 alveolar rhabdomyosarcoma cases 0.455418 gene-negative alveolar rhabdomyosarcoma 0.459372 typical embryonal rhabdomyosarcoma 0.456569 metastatic rhabdomyosarcoma 0.445146 group iii rhabdomyosarcoma 0.483139 Abstract 0.667848 Clin Oncol 0.743964 Intergroup Rhabdomyosarcoma Study-II 0.496765 Oncol Biol Phys 0.753212 rhabdomyosarcoma experience relapse 0.449214 tissue sarcoma committee 0.500618 orbital rhabdomyosarcoma 0.45917 alveolar rhabdomyosarcoma 0.600282 lymph node 0.533988 cell rhabdomyosarcoma patients 0.482049 intergroup rhabdomyosarcoma 0.827615 embryonal rhabdomyosarcoma 0.685831 oncology group 0.614164	CLICK HERE
1414	National Cancer Institute	Html	en	Hot Flashes and Night Sweats (PDQ®)–Patient Version	Expert-reviewed information summary about causes and treatment of hot flashes and night sweats in cancer patients.	cancer treatment 0.577378 breast cancer growth 0.57462 PDQ Hot Flashes 0.643088 PDQ cancer information 0.710576 clinical trial search 0.554702 clinical trials 0.684197 body temperature 0.616838 health care providers 0.555017 cancer information summary 0.634163 severe hot flashes 0.621374 clinical trial 0.594616 breast cancer prevention 0.567917 PDQ health 0.569751 PDQ summaries 0.568709 patients 0.592891 cancer patients 0.574113 latest published information 0.55886 estrogen -like substances 0.556219 NCI’s PDQ 0.568469 NCI PDQ cancer 0.6094 cancer survivors 0.55389 hot flashes 0.920465 treatment 0.612089 night sweats 0.802654	estrogen replacement 0.579416 psychological interventions 0.568926 breast cancer recurrence 0.578473 Cancer Information Service 0.575801 PDQ Supportive 0.564083 estrogen replacement therapy 0.560222 treatment clinical trials 0.565907 National Cancer Institute 0.636027 nighttime hot flashes 0.618591 PDQ documents 0.563513 Palliative Care Editorial 0.58817 new treatment 0.567162 Cancer Care page 0.56849 PDQ database 0.566974 breast cancer 0.719649 Care Editorial Board 0.588937 PDQ summary 0.580639 prostate cancer 0.599276 cancer clinical trials 0.581073 high blood pressure 0.551027 cancer information summaries 0.580862 health professional versions 0.550098 comprehensive cancer information 0.58061 cancer 0.738565	CLICK HERE
1528	National Cancer Institute	Html	en	Ovarian Low Malignant Potential Tumors Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of ovarian low-malignant potential tumors.	currently used treatment 0.491433 treatment 0.80031 abnormal cells 0.591776 cancer treatment 0.491469 ovaries 0.553108 abdomen 0.566902 body cavity 0.495458 NCI-supported cancer 0.497228 tissue 0.516419 cancer cells 0.493195 body 0.515176 Cancer Information Service 0.489344 low malignant potential 0.507879 PDQ cancer information 0.620272 clinical trial search 0.566415 uterus 0.498028 treatment clinical trials 0.555055 National Cancer Institute 0.572253 clinical trials 0.964888 tumor cells 0.695966 Treatment Options section 0.484079 cancer information summary 0.567078 clinical trial 0.741404 new treatment 0.564234	disease 0.554973 malignant potential tumor 0.900634 new treatments 0.489278 patients 0.603036 earlier clinical trials 0.497766 clinical trials database 0.496798 peritoneal cavity 0.517264 Potential Tumors Treatment 0.491558 treatment clinical trial 0.511947 PDQ Adult Treatment 0.504736 NCI PDQ cancer 0.507801 ovary 0.536161 cancer clinical trials 0.578107 tests 0.498811 stage 0.7416 malignant potential tumors 0.621847 fallopian tubes 0.57444 treatment options 0.549139 Treatment Editorial Board 0.533517 cancer information summaries 0.487894 comprehensive cancer information 0.488381 cancer 0.721628 standard treatment 0.552748	CLICK HERE
1686	National Cancer Institute	Html	en	Family Caregivers in Cancer (PDQ®)–Patient Version	Expert-reviewed information summary about the challenges faced by family caregivers of cancer patients. This summary focuses on typical caregiver roles and concerns, and helpful interventions for caregivers.	caregiver important information 0.22262 caregiver strain 0.371983 treatment 0.253353 family caregivers 0.362406 family caregiver changes 0.244372 Family Caregiver Cancer 0.223982 caregivers 0.69556 health care team 0.853882	caregiver assessment 0.244811 caregiver 0.956966 patient 0.749025 caregiver distress 0.215995 family caregiver 0.474179 caregiver role 0.201845 cancer 0.481346 information 0.329903	CLICK HERE
1758	National Cancer Institute	Html	en	Radiation Therapy for Cancer	A fact sheet that defines the different types of radiation therapy and discusses scientific advances that improve the effectiveness of this treatment.	radiation beam-shaping devices 0.405709 cancer treatment 0.383308 radiation damage 0.388785 continuous low-dose radiation 0.400269 whole-brain radiation therapy 0.419192 clinical trials 0.384103 brachytherapy 0.350611 smaller radiation fields 0.402818 high-energy radiation 0.421756 radiation therapy kill 0.43549 neoadjuvant radiation 0.393279 high radiation doses 0.407974 radiation monitors 0.387758 exact radiation plan 0.408331 normal tissue 0.471558 Image-guided radiation therapy 0.421303 body radiation therapy 0.425833 radiation therapy machine 0.421108 radiation therapy 0.980996 radiation doses 0.416676 treatment 0.462098 cancer cells 0.462619 radiation exposure 0.418968 3-dimensional conformal radiation therapy 0.42971 radiation oncologists 0.38961	adjuvant radiation therapy 0.411117 treatment planning 0.350359 total radiation dose 0.44244 radiation energy 0.401543 standard external-beam radiation 0.404865 patient 0.382556 radiation source 0.404836 radiation side effects 0.390501 Stereotactic body radiation 0.413552 delivers radiation therapy 0.41809 palliative radiation therapy 0.444425 radiation delivery 0.401163 Intensity-modulated radiation therapy 0.422003 external-beam radiation therapy 0.67618 publications Radiation Therapy 0.411985 systemic radiation therapy 0.554464 radiation treatment 0.409027 traditional radiation therapy 0.410276 radiation sources 0.408845 electromagnetic radiation 0.398457 tumor 0.381132 intraoperative radiation therapy 0.411493 internal radiation therapy 0.476394 radiation therapy drugs 0.418615	CLICK HERE
2041	National Cancer Institute	Html	es	Exámenes de detección del cáncer de vejiga y otros cánceres uroteliales (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de las pruebas que se usan para detectar sistemáticamente el cáncer de vejiga.	antecedentes familiares 0.40081 Schistosoma haematobium 0.417111 Visuals Online 0.357081 PDQ Exámenes 0.503031 Physician Data Query 0.696072 Estados Unidos 0.406708 túbulos renales 0.432914 prevención revisa 0.368302 sistema urinario masculino 0.518469	largo plazo 0.406946 vejiga almacena 0.840919 información ayuda 0.374743 biopsia.ampliar cistoscopia 0.431465 National Cancer Institute 0.400139 siguientes riesgos 0.364163 pelvis renal 0.934476 Instituto Nacional 0.483729	CLICK HERE
14599	National Cancer Institute	Html	en	PET-CT–Guided Surveillance May Reduce Need for Surgery in Some Patients with Advanced Head and Neck Cancer	Patients with advanced squamous cell carcinoma of the head and neck who underwent PET-CT–guided surveillance had fewer operations but similar overall survival rates to those of patients who underwent planned neck dissection.	fewer neck dissections 0.480753 different PET-imaging systems 0.416156 trial 0.383529 surgical dissection 0.49691 surgery group 0.546725 equivocal response 0.373027 main goal 0.370069 standard first-line therapy 0.446339 2-year overall survival 0.421723 results 0.372041 PET-CT–guided surveillance 0.384586 PET-CT group 0.386097 advanced squamous cell 0.578344 standardized PET imaging 0.419169 heterogeneous study population 0.413368 2,200-per-patient cost savings 0.413451 study groups 0.42202 patients 0.610711 metabolic abnormalities 0.37096 Dr. Malik 0.419332 health care costs 0.414997 lymph nodes 0.375275 overall survival rates 0.55552 surveillance group 0.491325	chemoradiation 0.396529 Shakun Malik 0.372291 nodal metastases 0.375714 positron-emission tomography 0.373068 magnetic resonance imaging 0.431542 Cancer Research UK 0.422638 Technology Assessment Programme 0.42519 United States 0.41309 N3 disease 0.374897 fewer operations 0.382441 randomized controlled PET-NECK 0.429823 PET-CT imaging 0.485125 advanced imaging techniques 0.434786 neck dissection 0.819668 PET-CT surveillance 0.497223 neck dissection patients 0.544115 Hisham Mehanna 0.370962 long-term results 0.369928 trial results 0.371832 United Kingdom 0.369679 cancer treatment centers 0.428263 substantial complications 0.369604 New England Journal 0.442645 clinical usefulness 0.371858	CLICK HERE
16862	National Cancer Institute	Html	es	Terapia Gerson (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre el uso de la terapia Gerson como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	diet therapy after 0.308285 Gerson therapies 0.323938 cancer treatment 0.320934 low sodium diet 0.305659 Regional Cancer Therapy 0.308916 Exp Med Surg 0.311537 Sin embargo 0.310104 cancer therapy 0.362986 San Diego 0.316933 Fifty Cases 0.313326 Unconventional Cancer Treatments 0.306866 malignant tumors 0.306376 preliminary report 0.312542 CA Cancer 0.311309 dieta gerson 0.372353 Gerson Research Organization 0.324799 Instituto Nacional 0.324032 suero lácteo 0.306238 Walker M 0.306008 régimen gerson 0.39009 PDQ Terapia Gerson 0.32794 Estados Unidos 0.310808 método gerson 0.324606 Rev Gastroenterol 0.312306 Nueva York 0.309059	Charlotte Gerson Straus 0.324657 gerson therapy 0.37388 Liebow C 0.304873 Physiol Chem Phys 0.339192 Hospital Gerson 0.32512 Gerson M 0.587193 clinical experimentation 0.312661 PDQ Régimen Gonzalez 0.309341 Gerson C 0.344712 National Cancer Institute 0.306378 combined dietary 0.306376 Kensington Publishing Corp 0.310101 vitamina b12 0.310902 diet therapy 0.393116 New York 0.309477 advanced cancer 0.355076 accessed april 0.313019 Amazing Nutritional Program 0.311171 enzimas pancreáticas 0.373196 Dietary considerations 0.313324 Gerson Institute 0.453889 Other Illnesses 0.306194 Max Gerson 0.406639 terapia gerson 0.96769	CLICK HERE
17292	National Cancer Institute	Html	es	Sangrado y moretones (trombocitopenia)	Información y consejos para controlar el sangrado y los moretones, los cuales son efectos secundarios del tratamiento del cáncer.	lip balm 0.762223		CLICK HERE